002370 Zhejiang Yatai Pharmaceutical
- 3.61
- +0.02+0.56%
Zhejiang Yatai Pharmaceutical News
Asia Pacific Pharmaceutical: Notice on the Company\'s Obtaining a Notice of Approval of the Drug Supplement Application
Asia Pacific Pharmaceutical: Notice on holding the first bondholders\' meeting in 2024
Asia Pacific Pharmaceutical: Announcement on Resolutions of the 18th Meeting of the 7th Board of Supervisors
Asia Pacific Pharmaceutical: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Asia Pacific Pharmaceutical: Announcement on the termination of the convertible bond fund-raising investment project
Asia Pacific Pharmaceutical: Announcement on the cumulative amount of debt-for-equity swaps of Asia Pharmaceuticals reaching 10% of the total amount of shares issued by the company before the share conversion
Asia Pacific Pharmaceutical: China Investment Securities Co., Ltd.\'s verification opinion on Zhejiang Asia Pacific Pharmaceutical Co., Ltd. terminating a fund-raising investment project with convertible bonds
Asia Pacific Pharmaceutical: Announcement on Resolutions of the 33rd Meeting of the 7th Board of Directors
Asia Pacific Pharmaceutical: Announcement on early return of funds raised for temporary supplementary working capital
Asia Pacific Pharmaceutical: Announcement on the cumulative amount of debt-for-equity swaps of Asia Pharmaceuticals reaching 10% of the total amount of shares issued by the company before the share conversion
Asia Pacific Pharmaceutical: Progress Announcement on Wholly-owned Subsidiaries Providing Guarantees for the Company\'s Financing
Asia Pacific Pharmaceuticals: Notice on Receipt of Civil Judgment
Asia Pacific Pharmaceutical: Announcement on the freezing of the company\'s bank account
Asia Pacific Pharmaceutical: Announcement on the company\'s injectable pantoprazole sodium passing the generic drug consistency evaluation
Asia Pacific Pharmaceutical: Notice on receiving the acceptance notice for the consistency evaluation of diltiazem hydrochloride tablets
Asia Pacific Pharmaceutical: Announcement on Atomic Company\'s completion of the registration of capital reduction and commercial changes
Asia Pacific Pharmaceutical: Announcement on the progress of liquidation and cancellation of joint ventures
Asia Pacific Pharmaceutical: Report for the third quarter of 2024
Asia Pacific Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2024
Asia Pacific Pharmaceutical: Announcement on Sale of 100% Shares in Wholly-owned Subsidiaries and Debt Forgiveness
No Data
